跳转至内容
Merck
CN

T3301

Sigma-Aldrich

Transforming Growth Factor-β1 Receptor II Soluble Fragment human

≥97% (SDS-PAGE), recombinant, expressed in mouse NSO cells, lyophilized powder

别名:

TGF-β1 RII

登录查看公司和协议定价

选择尺寸


关于此项目

MDL编号:
UNSPSC代码:
51111800
NACRES:
NA.41
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

重组

expressed in mouse NSO cells

方案

≥97% (SDS-PAGE)

表单

lyophilized powder

杂质

endotoxin, tested

储存温度

−20°C

一般描述

Transforming growth factor-β (TGF-β) belongs to the TGF-β superfamily of secreted proteins. The TGF-β family is involved in a variety of signaling pathways that involve serine/threonine protein kinases. TGF-β acts through binding to three transmembrane receptors in mammals, type I, type II and type III receptors. It is expressed by most cell types and regulates the DNA-binding activity of transcription factors. The important pathways regulated by TGF-β are the SMAD, BMP, MAPK and PI3K/Akt pathways. TGF-β is involved in cell and tissue differentiation, proliferation, morphogenesis, secretion of metalloproteases and inflammation. Deregulation of TGF-β signaling has been implicated in many developmental syndromes and cancer progression
Recombinant, human TGF-β1 soluble receptor II will bind to TGF-β1, -β2, -β3, and -β5.

应用

Recombinant, human TGF-β1 sRII may be used to inhibit TGF-β1 activity on mouse T cell line, HT-2.

外形

Lyophilized from 0.2 μm filtered phosphate buffered saline containing 1.25 mg bovine serum albumin

分析说明

The receptor mediated activity of human TGF-β1 receptor II soluble fragment is measured by its ability to inhibit the TGF-β1 bioactivity in HT-2 cells.

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Justin P Annes et al.
Journal of cell science, 116(Pt 2), 217-224 (2002-12-17)
TGFbeta is secreted as part of a latent complex that is targeted to the extracellular matrix. A variety of molecules, 'TGFbeta activators,' release TGFbeta from its latent state. The unusual temporal discontinuity of TGFbeta synthesis and action and the panoply
Pinglong Xu et al.
FEBS letters, 586(14), 1871-1884 (2012-05-24)
TGF-β family signaling through Smads is conceptually a simple and linear signaling pathway, driven by sequential phosphorylation, with type II receptors activating type I receptors, which in turn activate R-Smads. Nevertheless, TGF-β family proteins induce highly complex programs of gene
Rik Derynck et al.
Nature, 425(6958), 577-584 (2003-10-10)
Transforming growth factor-beta (TGF-beta) proteins regulate cell function, and have key roles in development and carcinogenesis. The intracellular effectors of TGF-beta signalling, the Smad proteins, are activated by receptors and translocate into the nucleus, where they regulate transcription. Although this
Joan Massagué et al.
FEBS letters, 586(14), 1953-1958 (2012-06-20)
The canonical TGF-β/Smad signaling pathway was delineated in the mid 90s and enriched over the past decade with many findings about its specificity, regulation, networking, and malfunctions in disease. However, a growing understanding of the chromatin status of a critical
Zhike Zi et al.
FEBS letters, 586(14), 1921-1928 (2012-06-20)
The physiological responses to TGF-β stimulation are diverse and vary amongst different cell types and environmental conditions. Even though the principal molecular components of the canonical and the non-canonical TGF-β signaling pathways have been largely identified, the mechanism that underlies

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持